by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Acute lung injury models play a fundamental role in respiratory drug development by allowing researchers to investigate the biological mechanisms that drive severe pulmonary inflammation and tissue damage. These models are widely used throughout preclinical...
by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Pulmonary fibrosis preclinical models play a critical role in respiratory drug development by helping researchers understand the mechanisms that drive progressive lung scarring and evaluate new therapeutic approaches before clinical trials begin. Pulmonary fibrosis is...
by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Proof of concept studies are a critical milestone in respiratory drug development. Before a therapeutic candidate progresses into large-scale preclinical programmes or clinical trials, researchers need evidence that it produces the intended biological effect. Proof of...
by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Preclinical efficacy testing is one of the most important stages of respiratory drug development. Before a new therapeutic candidate progresses into clinical trials, researchers must demonstrate that it produces meaningful biological effects within carefully designed...
by Virtus | Jun 28, 2026 | Respiratory Preclinical Research
Respiratory biomarkers have become one of the most valuable tools in modern respiratory drug development. They provide measurable biological indicators that help researchers understand disease progression, evaluate therapeutic responses and improve decision-making...
by Virtus | Jun 28, 2026 | Respiratory Preclinical Research
Translational respiratory research is one of the most important stages in modern respiratory drug development. While preclinical respiratory research provides valuable insight into disease biology and therapeutic efficacy, translational research ensures that these...
